Abstract: In this paper, 100 clinical research reports for Houttuynia Injection were collected and analyzed, including 8200 cases, among which 7460 cases were effective (with the effective rate of 90.98%), 40 cases showed adverse reactions (with the rate of adverse reaction of 0.49%), and no case of circulatory collapsed or dead. And also, 126 reports of individual cases about adverse reactions of Houttuynia Injection were collected, in which 201 cases showed adverse reactions, 123 cases showed allergic reactions (with the rate in the total cases of 61.19%), and 6 cases were dead. Because there was no sum total of the cases for Houttuynia Injection, the rate of adverse reaction could not be calculated. An analysis of the adverse reactions of the 201 cases shows that in 192 cases, the adverse reactions appear within the 30 minutes of the first injection (with the rate in the total cases of 95.5%). It is shown that Houttuynia Injection has a notable curative effect with rapid speed, and its rate and severity of adverse reaction are all lower than those of pharmaceutical chemicals and its injections. In addition, the adverse reactions of Houttuynia Injection are mainly acute anaphylactoid reactions. Thus, the re-evaluation of Houttuynia Injection should focus on its security, especially on the acute anaphylactoid reactions induced by Houttuynia Injection.
|
Received: 21 June 2010
|
Corresponding Authors:
Lian-Da LI
|
|
|
|